|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraceptives: recent safety studies (author's transl) [Contraceptifs |
| oraux: recentes etudes de tolerance.] |
| Contraception, Fertilite, Sexualite. 1983 Sep;11(9):975-83. |
| Considerable research evidence now exists to suggest that the risks of oral contraceptive (OC) use were seriously |
| overestimated in earlier work. Because experimentation in medicine is never possible in the rigorous sense in which |
| it is employed in basic sciences, other sources of information must be substituted. Information on the dangers of |
| OC use has come from anecdotal reports, retrospective case control studies, prospective cohort studies, and |
| statistical analyses of deaths, each source being associated with specific problems of interpretation. Recent |
| findings of the Royal College of General Practitioners, the Walnut Creek Study, and the Oxford Study have suggested |
| a lowered incidence of malignant neoplasms in OC than in IUD or diaphragm users; a reduced incidence of breast |
| cancer although the relationship did not consistently achieve statistical significance, and a reduced incidence of |
| ovarian and endometrial cancer. The risks of cervical cancer among OC users appeared slightly higher but |
| disappeared when sexual behavior was controlled. Despite much concern with the possibility of postpill amenorrhea |
| and perhaps sterility among women discontinuing OC use, it now appears that after 2 years there is no difference in |
| the fertility of women who have discontinued use of OCs, IUDs, or diaphragms. Use of OCs as a contraceptive before |
| pregnancy does not appear to be associated with fetal malformations, spontaneous abortion, or perinatal mortality, |
| and the inadvertent use of OCs in early pregnancy is apparently associated with only a very slight risk of anomalies. |
| Recent studies of cardiovascular disease risks indicate that the relative risks of cardiovascular disease among OC |
| users have been greatly exaggerated, especially when smoking is taken into account. Various studies of mortality |
| data have failed to establish a link between OC use and excess mortality from cardiovascular disease. |
| (PubHealth.info Document ID: CONT5T 2079-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives: recent safety studies (author's transl) |
| [Contraceptifs oraux: recentes etudes de tolerance.]", is(are) Edgren RA. The source of this article is |
| "Contraception, Fertilite, Sexualite. 1983 Sep;11(9):975-83.". This article was published in 1983 in French |
| language(s). (PubHealth.info® Document ID: CONT5T 2079-06. All rights reserved with PubHealth.info) PIN: 22079 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |